Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQC2731 in moderate to severe COPD
NCT06707883Phase 2Active, not recruiting
- Sponsor
- Chia Tai Tianqing
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- IgG Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bosakitug in chronic obstructive pulmonary disease (COPD), sponsored by Chia Tai Tianqing. Started Dec 2024; status: active, not recruiting.
02
Drugs
bosakitug
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06707883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06707883.